{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:15:42Z","timestamp":1792023342234,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01750-8","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T12:53:05Z","timestamp":1750164785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinicopathological features and renal outcomes in patients with IgA nephropathy secondary to psoriasis"],"prefix":"10.1007","volume":"25","author":[{"given":"Dafeng","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"9997","key":"1750_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"W-H Boehncke","year":"2015","unstructured":"Boehncke W-H, Sch\u00f6n MP. Psoriasis. Lancet. 2015;386(9997):983\u201394.","journal-title":"Lancet"},{"issue":"1","key":"1750_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.det.2014.09.001","volume":"33","author":"SK Mahil","year":"2015","unstructured":"Mahil SK, Capon F, Barker JN. Genetics of psoriasis. Dermatol Clin. 2015;33(1):1\u201311.","journal-title":"Dermatol Clin"},{"key":"1750_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaut.2016.12.002","volume":"78","author":"RA Pollock","year":"2017","unstructured":"Pollock RA, Abji F, Gladman DD. Epigenetics of psoriatic disease: a systematic review and critical appraisal. J Autoimmun. 2017;78:29\u201338.","journal-title":"J Autoimmun"},{"issue":"5","key":"1750_CR4","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle FO, Kaplan DH, Jonathan B. Psoriasis. N Engl J Med. 2009;361(5):496\u2013509.","journal-title":"N Engl J Med"},{"issue":"3","key":"1750_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1750_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/bjd.13599","volume":"173","author":"HY Chiu","year":"2015","unstructured":"Chiu HY, et al. Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study. Br J Dermatol. 2015;173(1):146\u201354.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1750_CR7","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jdermsci.2015.03.012","volume":"78","author":"CC Chi","year":"2015","unstructured":"Chi CC, et al. Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci. 2015;78(3):232\u20138.","journal-title":"J Dermatol Sci"},{"key":"1750_CR8","doi-asserted-by":"publisher","first-page":"f5961","DOI":"10.1136\/bmj.f5961","volume":"347","author":"J Wan","year":"2013","unstructured":"Wan J, et al. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ. 2013;347:f5961.","journal-title":"BMJ"},{"key":"1750_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1175477","author":"X Jing","year":"2023","unstructured":"Jing X, Zhuyuan W, Aijun C, Jianxia X, Kun H, Ping W. Association of psoriasis with chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis. Front Med. 2023. https:\/\/doi.org\/10.3389\/fmed.2023.1175477.","journal-title":"Front Med"},{"issue":"5","key":"1750_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1159\/000013388","volume":"18","author":"TS Ahuja","year":"1998","unstructured":"Ahuja TS, Funtanilla M, de Groot JJ, Velasco A, Badalamenti J, Wilson S. IgA nephropathy in psoriasis. Am J Nephrol. 1998;18(5):425\u20139. https:\/\/doi.org\/10.1159\/000013388.","journal-title":"Am J Nephrol"},{"issue":"3","key":"1750_CR11","first-page":"382","volume":"19","author":"J Zadrazil","year":"2006","unstructured":"Zadrazil J, Tich\u00fd T, Hor\u00e1k P, Nikorjakov\u00e1 I, Z\u00edma P, Krejc\u02c7\u00ed K, Strebl P. IgA nephropathy associated with psoriasis vulgaris: a contribution to the entity of \u201cpsoriatic nephropathy.\u201d J Nephrol. 2006;19(3):382\u20136.","journal-title":"J Nephrol."},{"issue":"5","key":"1750_CR12","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/bjd.14961","volume":"176","author":"SK Grewal","year":"2017","unstructured":"Grewal SK, Wan J, Denburg MR, Shin DB, Takeshita J, Gelfand JM. The risk of IgA nephropathy and glomerular disease in patients with psoriasis: a population-based cohort study. British J Dermatol. 2017;176(5):1366\u20139. https:\/\/doi.org\/10.1111\/bjd.14961.","journal-title":"British J Dermatol"},{"issue":"4","key":"1750_CR13","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","volume":"27","author":"W Le","year":"2012","unstructured":"Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population. Nephrol Dial Transplant. 2012;27(4):1479\u201385. https:\/\/doi.org\/10.1093\/ndt\/gfr527.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"1750_CR14","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ki.2009.168","volume":"76","author":"IS Roberts","year":"2009","unstructured":"Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Working Group of the International Ig ANN. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009;76(5):546\u201356.","journal-title":"Kidney Int."},{"issue":"9","key":"1750_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Int Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Int Med"},{"issue":"2","key":"1750_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1681\/ASN.2016040433","volume":"28","author":"M Haas","year":"2017","unstructured":"Haas M, Verhave JC, Liu Z-H, Alpers CE, Barratt J, Becker JU, et al. A multicenter study of the predictive value of crescents in iga nephropathy. J Am Soc Nephrol. 2017;28(2):691\u2013701. https:\/\/doi.org\/10.1681\/ASN.2016040433.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1750_CR17","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/ki.2009.243","volume":"76","author":"DC Cattran","year":"2009","unstructured":"Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534\u201345.","journal-title":"Kidney Int."},{"key":"1750_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23638-2","author":"X Huang","year":"2018","unstructured":"Huang X, Xiaomei W, Le W, Hao Y, Jing W, Zeng C, Liu Z, Tang Z. Renal prognosis and related risk factors for henoch-sch\u00f6nlein purpura nephritis: a chinese adult patient cohort. Sci Rep. 2018. https:\/\/doi.org\/10.1038\/s41598-018-23638-2.","journal-title":"Sci Rep"},{"issue":"5","key":"1750_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.ajkd.2012.06.011","volume":"60","author":"CH Zeng","year":"2012","unstructured":"Zeng CH, Weiboeng L, et al. A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis. 2012;60(5):812\u201320.","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"1750_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11255-011-9966-1","volume":"44","author":"E Dervisoglu","year":"2012","unstructured":"Dervisoglu E, Akturk AS, Yildiz K, Kiran R, Yilmaz A. The spectrum of renal abnormalities in patients with psoriasis. Int Urol Nephrol. 2012;44(2):509\u201314. https:\/\/doi.org\/10.1007\/s11255-011-9966-1.","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"1750_CR21","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/ndt\/gfad089","volume":"38","author":"L Jian","year":"2023","unstructured":"Jian L, Li H, Wang S. Interaction effect of psoriasis and chronic kidney disease on the risk of all-cause mortality: a prospective cohort study of NHANES data. Nephrol Dial Transplant. 2023;38(11):2474\u201384. https:\/\/doi.org\/10.1093\/ndt\/gfad089.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"1750_CR22","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jaad.2023.06.011","volume":"89","author":"JR Xu","year":"2023","unstructured":"Xu JR, Zheng DX, Ahn AB, Ahmad AS, O\u2019Connell KA, Cwalina TB, Sharma TR, Ho RS. Psoriasis and chronic kidney disease among the United States adult population. J Am Acad Dermatol. 2023;89(4):834\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2023.06.011.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"1750_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/nep.14220","volume":"28","author":"S Yin","year":"2023","unstructured":"Yin S, Zhou Z, Jiapei W, Wang X, Lin T. Psoriasis and risk of chronic kidney diseases: a population\u2010based cross\u2010sectional study and Mendelian randomization analysis. Nephrology. 2023;28(11):611\u20139. https:\/\/doi.org\/10.1111\/nep.14220.","journal-title":"Nephrology"},{"issue":"7","key":"1750_CR24","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s11255-018-1868-z","volume":"50","author":"P Ungprasert","year":"2018","unstructured":"Ungprasert P, Raksasuk S. Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. 2018;50(7):1277\u201383.","journal-title":"Int Urol Nephrol."},{"issue":"1","key":"1750_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s12016-018-8668-1","volume":"54","author":"CGM Conrad","year":"2018","unstructured":"Conrad CGM. Psoriasis: from pathogenesis to targeted therapies. Clin Rev Allergy Immunol. 2018;54(1):102\u201313.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"1750_CR26","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/bjd.14913","volume":"176","author":"SOH Coimbra","year":"2017","unstructured":"Coimbra SOH, Rocha-Pereira P, Figueiredo A, Santos-Silva A. The cross-talk between renal function, inflammation and psoriasis vulgaris. Br J Dermatol. 2017;176(3):829\u201331.","journal-title":"Br J Dermatol"},{"issue":"12","key":"1750_CR27","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1111\/j.1468-3083.2010.03647.x","volume":"24","author":"S Coimbra","year":"2010","unstructured":"Coimbra S, Oliveira H, Reis F, et al. Circulating adipokine levels in Portuguese patients with psoriasis vulgaris according to body mass index, severity and therapy. J Eur Acad Dermatol Venereol. 2010;24(12):1386\u201394.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"7","key":"1750_CR28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/j.1468-3083.2009.03527.x","volume":"24","author":"S Coimbra","year":"2010","unstructured":"Coimbra S, Oliveira H, Reis F, et al. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol. 2010;24(7):789\u201396.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"2","key":"1750_CR29","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1111\/ijd.16903","volume":"63","author":"S Kulakl\u0131","year":"2024","unstructured":"Kulakl\u0131 S, Akag\u00fcn T. A case of psoriasis with IgA nephropathy successfully treated with secukinumab. Int J Dermatol. 2024;63(2):e35\u20137.","journal-title":"Int J Dermatol."},{"issue":"1","key":"1750_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1365-2133.1977.tb05194.x","volume":"96","author":"H Tagami","year":"1977","unstructured":"Tagami H, Ofuji S. Demonstration of C3 cleavage product in leukotactic substances of scale extract from pustular psoriasis. British J Dermatol. 1977;96(1):94\u20135.","journal-title":"British J Dermatol."},{"issue":"3","key":"1750_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/1523-1747.ep12506623","volume":"78","author":"VC Weiss","year":"1982","unstructured":"Weiss VC, van Den Broek H, Barrett S, West DP. Immunopathology of psoriasis: a comparison with other parakeratotic lesions. J Invest Dermatol. 1982;78(3):256\u201360.","journal-title":"J Invest Dermatol."},{"issue":"6","key":"1750_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1365-2230.1996.tb00144.x","volume":"21","author":"CJ Fleming","year":"1996","unstructured":"Fleming CJ, Holme SE, Mackie RM. Systemic complement activation in psoriasis vulgaris. Clin Exp Dermatol. 1996;21(6):415\u20138.","journal-title":"Clin Exp Dermatol."},{"key":"1750_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10067-015-3126-4","volume":"35","author":"L Visconti","year":"2016","unstructured":"Visconti L, Leonardi G, Buemi M, Santoro D, Cernaro V, Ricciardi CA, Lacquaniti A, Coppolino G. Kidney disease and psoriasis: novel evidences beyond old concepts. Clinical Rheumatol. 2016;35:297\u2013302.","journal-title":"Clinical Rheumatol."},{"issue":"2","key":"1750_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2340\/0001555572138140","volume":"72","author":"B Gasior-Chrzan","year":"1992","unstructured":"Gasior-Chrzan B, Falk ES. Lysozyme and IgA concentrations in serum and saliva from psoriatic patients. Acta dermato-venereologica. 1992;72(2):138\u201340.","journal-title":"Acta dermato-venereologica."},{"issue":"1","key":"1750_CR35","first-page":"64","volume":"44","author":"H Imai","year":"1995","unstructured":"Imai H, Kodama T, Ishino T, Yasuda T, Miura AB, Asakura K, Nishimura S, Nakamoto Y. IgA nephropathy associated with hyperIgAnemia, psoriasis or pustulosis and ossification. Clin Nephrol. 1995;44(1):64\u20138.","journal-title":"Clin Nephrol."},{"issue":"4","key":"1750_CR36","first-page":"225","volume":"176","author":"HJ Koch","year":"1990","unstructured":"Koch HJ, Wollina U, Seyfarth M, Thiel W, Schaarschmidt H. Detection of IgA in diseased skin and serum of patients with psoriasis vulgaris. Dermatol Monatsschr. 1990;176(4):225\u201331.","journal-title":"Dermatol Monatsschr."},{"issue":"3","key":"1750_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000087019","volume":"211","author":"M Ozawa","year":"2005","unstructured":"Ozawa M, Terui T, Tagami H. Localization of IL-8 and complement components in lesional skin of psoriasis vulgaris and pustulosis palmaris et plantaris. Dermatology. 2005;211(3):249\u201355. https:\/\/doi.org\/10.1159\/000087019.","journal-title":"Dermatology"},{"issue":"1","key":"1750_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/rheumatology\/41.1.31","volume":"41","author":"U Lindqvist","year":"2002","unstructured":"Lindqvist U, Rudsander \u00c5, Bostr\u00f6m \u00c5, Nilsson B, Micha\u00eblsson G. IgA antibodies to gliadin and coeliac disease in psoriatic arthritis. Rheumatology. 2002;41(1):31\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/41.1.31.","journal-title":"Rheumatology"},{"issue":"4","key":"1750_CR39","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/gut.33.4.476","volume":"33","author":"C Sategna-Guidetti","year":"1992","unstructured":"Sategna-Guidetti C, et al. Do IgA antigliadin and IgA antiendomysium antibodies show there is latent coeliac disease in primary IgA nephropathy? Gut. 1992;33(4):476\u20138.","journal-title":"Gut."},{"issue":"2","key":"1750_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1468-3083.2011.04024.x","volume":"26","author":"A Damasiewicz-Bodzek","year":"2012","unstructured":"Damasiewicz-Bodzek A. Advanced protein glycation in psoriasis. J Eur Acad Dermatol Venereol. 2012;26(2):172\u20139.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"5","key":"1750_CR41","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1007\/s10157-013-0921-6","volume":"18","author":"Y Suzuki","year":"2014","unstructured":"Suzuki Y, Matsuzaki K, Suzuki H, et al. Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy. Clin Exp Nephrol. 2014;18(5):770\u20137. https:\/\/doi.org\/10.1007\/s10157-013-0921-6.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"1750_CR42","doi-asserted-by":"publisher","first-page":"e0190967","DOI":"10.1371\/journal.pone.0190967","volume":"13","author":"WJ Placzek","year":"2018","unstructured":"Placzek WJ, Yanagawa H, Makita Y, et al. Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy. PLOS ONE. 2018;13(1):e0190967. https:\/\/doi.org\/10.1371\/journal.pone.0190967.","journal-title":"PLOS ONE"},{"issue":"1","key":"1750_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ki.2011.16","volume":"80","author":"K Kiryluk","year":"2011","unstructured":"Kiryluk K, et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis. Kidney Int. 2011;80(1):79\u201387.","journal-title":"Kidney Int."}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01750-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01750-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01750-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:51:05Z","timestamp":1764917465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01750-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1750"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01750-8","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"8 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the Research Ethics Committee of JMC-NMU (Approval Number: 2018NZKYKS-002\u201301). Due to the retrospective nature of the study, written informed consent for participation in the study was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"207"}}